Pain medication tapering for patients with Persistent Spinal Pain Syndrome Type II, treated with Spinal Cord Stimulation: A RCT-study protocol of the PIANISSIMO study.
<h4>Background</h4>Spinal Cord Stimulation (SCS) may provide pain relief in patients with therapy-refractory Persistent Spinal Pain Syndrome Type II (PSPS-T2). Despite the evidence that SCS can reduce disability and reduce pain medication usage, only 25% of the patients is able to comple...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2024-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0302842 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841560476844032000 |
|---|---|
| author | Maarten Moens Cleo Lina Crunelle Koen Putman Elke Wuyts Frenn Bultinck Hubert Van Puyenbroeck PIANISSIMO consortium Lisa Goudman |
| author_facet | Maarten Moens Cleo Lina Crunelle Koen Putman Elke Wuyts Frenn Bultinck Hubert Van Puyenbroeck PIANISSIMO consortium Lisa Goudman |
| author_sort | Maarten Moens |
| collection | DOAJ |
| description | <h4>Background</h4>Spinal Cord Stimulation (SCS) may provide pain relief in patients with therapy-refractory Persistent Spinal Pain Syndrome Type II (PSPS-T2). Despite the evidence that SCS can reduce disability and reduce pain medication usage, only 25% of the patients is able to completely omit pain medication usage after 12 months of SCS. To tackle the high burden of patients who consume a lot of pain medication, tapering programs could be initiated before starting a trajectory with SCS. The current objective is to examine whether a pain medication tapering program before SCS alters disability in PSPS-T2 patients compared to no tapering program.<h4>Methods and design</h4>A three-arm, parallel-group multicenter randomized controlled trial will be conducted including 195 patients who will be randomized (1:1:1) to either (a) a standardized pain medication tapering program, (b) a personalized pain medication tapering program, or (c) no tapering program before SCS implantation, all with a follow-up period until 12 months after implantation. The primary outcome is disability. The secondary outcomes are pain intensity, health-related quality of life, participation, domains affected by substance use, anxiety and depression, medication usage, psychological constructs, sleep, symptoms of central sensitization, and healthcare expenditure.<h4>Discussion</h4>Within the PIANISSIMO project we propose a way to reduce the risks of adverse events, medication-induced hyperalgesia, tolerance, and dependence by providing pain medication tapering before SCS. Due to the lack of a commonly accepted in-hospital tapering approach, two different tapering programs will be evaluated in this study. If pain medication tapering programs are deemed to be more effective than no tapering on disability, this would add to the evidence towards an improved patient-centered care model in this patient group and set a clear path to advocate for pain medication tapering before SCS as the new standard treatment guideline for these patients.<h4>Trial registration</h4>ClinicalTrials.gov NCT05861609. Registered on May 17, 2023. |
| format | Article |
| id | doaj-art-4c104cd8b86643baab8136ddd270014c |
| institution | Kabale University |
| issn | 1932-6203 |
| language | English |
| publishDate | 2024-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-4c104cd8b86643baab8136ddd270014c2025-01-04T05:30:46ZengPublic Library of Science (PLoS)PLoS ONE1932-62032024-01-01198e030284210.1371/journal.pone.0302842Pain medication tapering for patients with Persistent Spinal Pain Syndrome Type II, treated with Spinal Cord Stimulation: A RCT-study protocol of the PIANISSIMO study.Maarten MoensCleo Lina CrunelleKoen PutmanElke WuytsFrenn BultinckHubert Van PuyenbroeckPIANISSIMO consortiumLisa Goudman<h4>Background</h4>Spinal Cord Stimulation (SCS) may provide pain relief in patients with therapy-refractory Persistent Spinal Pain Syndrome Type II (PSPS-T2). Despite the evidence that SCS can reduce disability and reduce pain medication usage, only 25% of the patients is able to completely omit pain medication usage after 12 months of SCS. To tackle the high burden of patients who consume a lot of pain medication, tapering programs could be initiated before starting a trajectory with SCS. The current objective is to examine whether a pain medication tapering program before SCS alters disability in PSPS-T2 patients compared to no tapering program.<h4>Methods and design</h4>A three-arm, parallel-group multicenter randomized controlled trial will be conducted including 195 patients who will be randomized (1:1:1) to either (a) a standardized pain medication tapering program, (b) a personalized pain medication tapering program, or (c) no tapering program before SCS implantation, all with a follow-up period until 12 months after implantation. The primary outcome is disability. The secondary outcomes are pain intensity, health-related quality of life, participation, domains affected by substance use, anxiety and depression, medication usage, psychological constructs, sleep, symptoms of central sensitization, and healthcare expenditure.<h4>Discussion</h4>Within the PIANISSIMO project we propose a way to reduce the risks of adverse events, medication-induced hyperalgesia, tolerance, and dependence by providing pain medication tapering before SCS. Due to the lack of a commonly accepted in-hospital tapering approach, two different tapering programs will be evaluated in this study. If pain medication tapering programs are deemed to be more effective than no tapering on disability, this would add to the evidence towards an improved patient-centered care model in this patient group and set a clear path to advocate for pain medication tapering before SCS as the new standard treatment guideline for these patients.<h4>Trial registration</h4>ClinicalTrials.gov NCT05861609. Registered on May 17, 2023.https://doi.org/10.1371/journal.pone.0302842 |
| spellingShingle | Maarten Moens Cleo Lina Crunelle Koen Putman Elke Wuyts Frenn Bultinck Hubert Van Puyenbroeck PIANISSIMO consortium Lisa Goudman Pain medication tapering for patients with Persistent Spinal Pain Syndrome Type II, treated with Spinal Cord Stimulation: A RCT-study protocol of the PIANISSIMO study. PLoS ONE |
| title | Pain medication tapering for patients with Persistent Spinal Pain Syndrome Type II, treated with Spinal Cord Stimulation: A RCT-study protocol of the PIANISSIMO study. |
| title_full | Pain medication tapering for patients with Persistent Spinal Pain Syndrome Type II, treated with Spinal Cord Stimulation: A RCT-study protocol of the PIANISSIMO study. |
| title_fullStr | Pain medication tapering for patients with Persistent Spinal Pain Syndrome Type II, treated with Spinal Cord Stimulation: A RCT-study protocol of the PIANISSIMO study. |
| title_full_unstemmed | Pain medication tapering for patients with Persistent Spinal Pain Syndrome Type II, treated with Spinal Cord Stimulation: A RCT-study protocol of the PIANISSIMO study. |
| title_short | Pain medication tapering for patients with Persistent Spinal Pain Syndrome Type II, treated with Spinal Cord Stimulation: A RCT-study protocol of the PIANISSIMO study. |
| title_sort | pain medication tapering for patients with persistent spinal pain syndrome type ii treated with spinal cord stimulation a rct study protocol of the pianissimo study |
| url | https://doi.org/10.1371/journal.pone.0302842 |
| work_keys_str_mv | AT maartenmoens painmedicationtaperingforpatientswithpersistentspinalpainsyndrometypeiitreatedwithspinalcordstimulationarctstudyprotocolofthepianissimostudy AT cleolinacrunelle painmedicationtaperingforpatientswithpersistentspinalpainsyndrometypeiitreatedwithspinalcordstimulationarctstudyprotocolofthepianissimostudy AT koenputman painmedicationtaperingforpatientswithpersistentspinalpainsyndrometypeiitreatedwithspinalcordstimulationarctstudyprotocolofthepianissimostudy AT elkewuyts painmedicationtaperingforpatientswithpersistentspinalpainsyndrometypeiitreatedwithspinalcordstimulationarctstudyprotocolofthepianissimostudy AT frennbultinck painmedicationtaperingforpatientswithpersistentspinalpainsyndrometypeiitreatedwithspinalcordstimulationarctstudyprotocolofthepianissimostudy AT hubertvanpuyenbroeck painmedicationtaperingforpatientswithpersistentspinalpainsyndrometypeiitreatedwithspinalcordstimulationarctstudyprotocolofthepianissimostudy AT pianissimoconsortium painmedicationtaperingforpatientswithpersistentspinalpainsyndrometypeiitreatedwithspinalcordstimulationarctstudyprotocolofthepianissimostudy AT lisagoudman painmedicationtaperingforpatientswithpersistentspinalpainsyndrometypeiitreatedwithspinalcordstimulationarctstudyprotocolofthepianissimostudy |